Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Fertility Services Market Research Report Information By Underlying Cause (Male Infertility and Female Infertility), By Treatment Type (ART, And Infertility Drugs), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032


ID: MRFR/HS/4820-CR | 108 Pages | Author: Kinjoll Dey| February 2021

Market Segmentation Tab


FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


FERTILITY SERVICES Regional Outlook (USD Billion, 2018-2030)



  • North America Outlook (USD Billion, 2018-2030)


FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • US Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • CANADA Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs

  • Europe Outlook (USD Billion, 2018-2030)


FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • Germany Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs

    • France Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • UK Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • ITALY Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • SPAIN Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • Rest Of Europe Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs

  • Asia-Pacific Outlook (USD Billion, 2018-2030)


FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • China Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • Japan Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • India Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • Australia Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs

  • Rest of the World Outlook (USD Billion, 2018-2030)


FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


 






    • Middle East Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • Africa Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


    • Latin America Outlook (USD Billion, 2018-2030)




FERTILITY SERVICES Underlying Cause Outlook (USD Billion, 2018-2030)



  • Male Infertility

  • Female Infertility


FERTILITY SERVICES Treatment Type Outlook (USD Billion, 2018-2030)



  • ART

  • Infertility Drugs


 

Research methodology on Fertility Services Market


1.0 Introduction


The research report titled “Global Fertility Services Market” published by Market Research Future (MRFR) provides an in-depth analysis of the fertility services market, along with an assessment of current trends, market dynamics, and their expected impact on the global fertility services market in near future and forecasts from 2023 to 2032. Moreover, this report also classifies the fertility services market into various segments and offers insights into market trends, drivers, opportunities, and challenges impacting the overall market.


2.0 Research Methodology


This research is an extensive quantitative and qualitative study of the global Fertility Services market. The research methodology employed in this research report involves extensive secondary research, followed by primary research. The primary research entailed one-on-one and face-to-face interviews. Secondary research includes data collated from company websites, industry white papers, journal articles, and databases. The report also draws insights from competitive landscape analysis and detailed market segmental analysis.


2.1 Data Collection


The data collection phase of the research is carried out through extensive secondary and primary research. In the secondary research phase, a comprehensive review of trade publications, news sites, and industry websites is conducted to capture data from a wide range of sources. In the primary research phase, interviews with senior executives and industry experts were conducted to collect in-depth information about the market, competitors’ strategies, and the market dynamics in different regions.


2.2 Research Strategy


The research strategy adopted to analyze the fertility services market is two-pronged – qualitative and quantitative. The qualitative approach is used to understand the market drivers, challenges, and regional trends affecting the growth of the market. The statistical data collated from various industry sources are used to analyze the market size, share, volume and future projections.


2.3 Market segmentation


The global fertility services market is segmented into product type, end-user, and region.


 


By product type, the market is segmented into infertility Donor Services & Cryopreservation, Ovum Donation & Frozen Embryo, IVF Procedures, Artificial Insemination, Egg Donation, Surrogacy, and Others.


By end-user, the market is segmented into Hospitals, Fertility Clinics & Centers, Ambulatory Surgery Centers, and Others.


By region, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (ROW).


2.4 Analysis Tools


The analysis tools used to capture the analysis of the fertility services market included SWOT Analysis, Porter’s Five Forces Analysis, and PESTEL Analysis. These various tools are employed to answer questions related to market developments, price structure, and industry trends that could affect the growth of the market during the forecast period. The focus is placed on the current market trends and how they are likely to shape the global fertility services market in the near future.


3.0 Expected Outcome/Conclusion


The fertility services market is expected to witness strong growth during the forecast period 2023 to 2032. Market players are focused on introducing new technologies and products to cater to a larger consumer base and cater to the increased demand for fertility services. The key players in the market are introducing new and advanced products for different types of fertility treatments to meet the growing demand for infertility treatments globally.


This report provides a detailed analysis of the market trends in different regions and provides insights into the competitive landscape and industry dynamics. Market players are innovating and launching new and advanced product offerings. Market players are focusing on enhancing their growth in different regions by taking advantage of government initiatives and regulations regarding fertility treatments. The market is expected to remain promising, as players are introducing new and innovative products and services for fertility treatments.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 EXECUTIVE SUMMARY

1.1 OVERVIEW 13

1.1.1 MARKET SYNOPSIS 13

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 14

2.2 RESEARCH OBJECTIVE 14

2.3 LIST OF ASSUMPTIONS & LIMITATIONS 14

3 RESEARCH METHODOLOGY

3.1 OVERVIEW 16

3.2 DATA MINING 16

3.3 SECONDARY RESEARCH 17

3.4 PRIMARY RESEARCH 18

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 19

3.5 FORECASTING TECHNIQUES 20

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21

3.6.1 BOTTOM-UP APPROACH 22

3.6.2 TOP-DOWN APPROACH 22

3.7 DATA TRIANGULATION 23

3.8 VALIDATION 23

4 MARKET DYNAMICS

4.1 OVERVIEW 24

4.2 DRIVERS 25

4.2.1 GROWTH IN THE MEDIAN AGE OF FIRST-TIME MOTHERHOOD AND DECLINING FERTILITY RATE 25

4.2.2 TECHNOLOGICAL ADVANCEMENTS IN FERTILITY TREATMENT 25

4.2.3 INCREASING PREVALENCE OF OBESITY AND CONSUMPTION OF ALCOHOL/CIGARETTES 25

4.2.4 DRIVERS IMPACT ANALYSIS 26

4.3 RESTRAINTS 26

4.3.1 HIGH PROCEDURAL COSTS OF ASSISTED REPRODUCTIVE TECHNIQUES IN DEVELOPED MARKETS 26

4.3.2 ETHICAL AND SOCIAL CONCERNS 27

4.3.3 RESTRAINTS IMPACT ANALYSIS 27

4.4 OPPORTUNITIES 28

4.4.1 REIMBURSEMENT FOR FERTILITY TREATMENTS 28

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 29

5.1.1 THREAT OF NEW ENTRANTS 29

5.1.2 BARGAINING POWER OF SUPPLIERS 30

5.1.3 THREAT OF SUBSTITUTES 30

5.1.4 BARGAINING POWER OF BUYERS 30

5.1.5 INTENSITY OF RIVALRY 30

5.2 VALUE CHAIN ANALYSIS 31

5.2.1 R&D AND DESIGNING 31

5.2.2 MANUFACTURING 32

5.2.3 DISTRIBUTION 32

5.2.4 MARKETING & SALES 32

5.2.5 POST-SALES MONITORING 32

5.3 COVID-19 IMPACT ANALYSIS 33

5.3.1 IMPACT ON GROWTH RATE 33

5.3.2 IMPACT ON MAJOR PLAYERS 33

5.3.3 IMPACT ON MAJOR REGIONS 33

6 GLOBAL FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE

6.1 OVERVIEW 34

6.2 FEMALE INFERTILITY 35

6.3 MALE INFERTILITY 36

7 GLOBAL FERTILITY SERVICES MARKET, BY TREATMENT TYPE

7.1 OVERVIEW 37

7.2 ASSISTED REPRODUCTIVE TECHNOLOGY (ART) 38

7.2.1 IN-VITRO FERTILIZATION (IVF) 39

7.2.2 FROZEN EMBRYO REPLACEMENT (FER) 39

7.2.3 ARTIFICIAL INSEMINATION 40

7.2.4 OTHERS 40

7.3 INFERTILITY DRUGS 41

8 GLOBAL FERTILITY SERVICES MARKET, BY REGION

8.1 OVERVIEW 42

8.2 EUROPE 43

8.2.1 WESTERN EUROPE 45

8.2.1.1 GERMANY 46

8.2.1.2 UK 47

8.2.1.3 FRANCE 48

8.2.1.4 ITALY 49

8.2.1.5 SPAIN 50

8.2.1.6 REST OF WESTERN EUROPE 51

8.2.2 EASTERN EUROPE 52

8.3 AMERICAS 54

8.3.1 NORTH AMERICA 56

8.3.1.1 US 57

8.3.1.2 CANADA 58

8.3.2 LATIN AMERICA 59

8.4 ASIA-PACIFIC 61

8.4.1 JAPAN 62

8.4.2 CHINA 63

8.4.3 INDIA 64

8.4.4 SOUTH KOREA 65

8.4.5 AUSTRALIA 66

8.4.6 REST OF ASIA PACIFIC 67

8.5 MIDDLE EAST & AFRICA 69

8.5.1 MIDDLE EAST 70

8.5.2 AFRICA 71

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW 73

9.2 MAJOR PLAYERS IN THE GLOBAL FERTILITY SERVICES MARKET 73

9.3 COMPETITIVE BENCHMARKING 74

9.4 COMPETITOR DASHBOARD 75

9.5 DEVELOPMENTS IN THE GLOBAL FERTILITY SERVICES MARKET 76

9.5.1 ACQUISITION 76

9.5.2 COLLABORATION 76

9.5.3 EXPANSION 76

9.5.4 DEVELOPMENT 77

9.5.5 JOINT VENTURE 77

9.5.6 PRODUCT LAUNCH/PRODUCT APPROVAL 77

10 COMPANY PROFILES

10.1 MERCK KGAA 78

10.1.1 COMPANY OVERVIEW 78

10.1.2 FINANCIAL OVERVIEW 79

10.1.3 PRODUCTS/SERVICES OFFERED 79

10.1.4 KEY DEVELOPMENTS 80

10.1.5 SWOT ANALYSIS 80

10.1.6 KEY STRATEGIES 81

10.2 COOPERSURGICAL, INC. 82

10.2.1 COMPANY OVERVIEW 82

10.2.2 FINANCIAL OVERVIEW 83

10.2.3 PRODUCTS/SERVICES OFFERED 83

10.2.4 KEY DEVELOPMENTS 84

10.2.5 SWOT ANALYSIS 85

10.2.6 KEY STRATEGIES 85

10.3 CARE FERTILITY 86

10.3.1 COMPANY OVERVIEW 86

10.3.2 FINANCIAL OVERVIEW 86

10.3.3 PRODUCTS/SERVICES OFFERED 86

10.3.4 KEY DEVELOPMENTS 87

10.3.5 SWOT ANALYSIS 87

10.3.6 KEY STRATEGIES 87

10.4 FERRING BV. 88

10.4.1 COMPANY OVERVIEW 88

10.4.2 FINANCIAL OVERVIEW 88

10.4.3 PRODUCTS/SERVICES OFFERED 88

10.4.4 KEY DEVELOPMENTS 89

10.4.5 SWOT ANALYSIS 89

10.4.6 KEY STRATEGIES 89

10.5 INVO BIOSCIENCE 90

10.5.1 COMPANY OVERVIEW 90

10.5.2 FINANCIAL OVERVIEW 90

10.5.3 PRODUCTS/SERVICES OFFERED 90

10.5.4 KEY DEVELOPMENTS 91

10.5.5 SWOT ANALYSIS 91

10.5.6 KEY STRATEGIES 91

10.6 VITROLIFE 92

10.6.1 COMPANY OVERVIEW 92

10.6.2 FINANCIAL OVERVIEW 92

10.6.3 PRODUCTS/SERVICES OFFERED 93

10.6.4 KEY DEVELOPMENTS 94

10.6.5 SWOT ANALYSIS 95

10.6.6 KEY STRATEGIES 95

10.7 MONASH IVF GROUP 96

10.7.1 COMPANY OVERVIEW 96

10.7.2 FINANCIAL OVERVIEW 96

10.7.3 PRODUCTS/SERVICES OFFERED 97

10.7.4 KEY DEVELOPMENTS 97

10.7.5 SWOT ANALYSIS 98

10.7.6 KEY STRATEGIES 98

10.8 COOK 99

10.8.1 COMPANY OVERVIEW 99

10.8.2 FINANCIAL OVERVIEW 99

10.8.3 PRODUCTS/SERVICES OFFERED 99

10.8.4 KEY DEVELOPMENTS 100

10.8.5 SWOT ANALYSIS 101

10.8.6 KEY STRATEGIES 101

10.9 FUJIFILM IRVINE SCIENTIFIC 102

10.9.1 COMPANY OVERVIEW 102

10.9.2 FINANCIAL OVERVIEW 102

10.9.3 PRODUCTS/SERVICES OFFERED 103

10.9.4 KEY DEVELOPMENTS 103

10.9.5 SWOT ANALYSIS 104

10.9.6 KEY STRATEGIES 104

10.10 KITAZATO CORPORATION 105

10.10.1 COMPANY OVERVIEW 105

10.10.2 FINANCIAL OVERVIEW 105

10.10.3 PRODUCTS/SERVICES OFFERED 105

10.10.4 KEY DEVELOPMENTS 106

10.10.5 SWOT ANALYSIS 106

10.10.6 KEY STRATEGIES 106

11 APPENDIX

11.1 REFERENCES 107

11.2 RELATED REPORTS 107

12 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 14

TABLE 2 GLOBAL FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 34

TABLE 3 GLOBAL FERTILITY SERVICES MARKET FOR FEMALE INFERTILITY, BY REGION, 2020-2027 (USD MILLION) 35

TABLE 4 GLOBAL FERTILITY SERVICES MARKET FOR MALE INFERTILITY, BY REGION, 2020-2027 (USD MILLION) 36

TABLE 5 GLOBAL FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 37

TABLE 6 GLOBAL FERTILITY SERVICES MARKET FOR ART, BY TYPE, 2020-2027 (USD MILLION) 38

TABLE 7 GLOBAL FERTILITY SERVICES MARKET FOR ART TREATMENT, BY REGION, 2020-2027 (USD MILLION) 39

TABLE 8 GLOBAL FERTILITY SERVICES MARKET FOR IN-VITRO FERTILIZATION (IVF), BY REGION, 2020-2027 (USD MILLION) 39

TABLE 9 GLOBAL FERTILITY SERVICES MARKET FOR FROZEN EMBRYO REPLACEMENT (FER), BY REGION, 2020-2027 (USD MILLION) 39

TABLE 10 GLOBAL FERTILITY SERVICES MARKET FOR ARTIFICIAL INSEMINATION, BY REGION, 2020-2027 (USD MILLION) 40

TABLE 11 GLOBAL FERTILITY SERVICES MARKET FOR OTHERS, BY REGION, 2020-2027 (USD MILLION) 40

TABLE 12 GLOBAL FERTILITY SERVICES MARKET FOR INFERTILITY DRUGS, BY REGION, 2020-2027 (USD MILLION) 41

TABLE 13 GLOBAL FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 42

TABLE 14 EUROPE: FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 43

TABLE 15 EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 44

TABLE 16 EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 44

TABLE 17 EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 44

TABLE 18 WESTERN EUROPE: FERTILITY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 45

TABLE 19 WESTERN EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 45

TABLE 20 WESTERN EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 46

TABLE 21 WESTERN EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 46

TABLE 22 GERMANY: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 46

TABLE 23 GERMANY: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 46

TABLE 24 GERMANY: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 47

TABLE 25 UK: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 47

TABLE 26 UK: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 47

TABLE 27 UK: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 48

TABLE 28 FRANCE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 48

TABLE 29 FRANCE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 48

TABLE 30 FRANCE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 49

TABLE 31 ITALY: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 49

TABLE 32 ITALY: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 49

TABLE 33 ITALY: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 50

TABLE 34 SPAIN: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 50

TABLE 35 SPAIN: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 50

TABLE 36 SPAIN: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 51

TABLE 37 REST OF WESTERN EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 51

TABLE 38 REST OF WESTERN EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 51

TABLE 39 REST OF WESTERN EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 52

TABLE 40 EASTERN EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 52

TABLE 41 EASTERN EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 52

TABLE 42 EASTERN EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 53

TABLE 43 AMERICAS: FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 54

TABLE 44 AMERICAS: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 55

TABLE 45 AMERICAS: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 55

TABLE 46 AMERICAS: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 55

TABLE 47 NORTH AMERICA: FERTILITY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 56

TABLE 48 NORTH AMERICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 56

TABLE 49 NORTH AMERICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 56

TABLE 50 NORTH AMERICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 57

TABLE 51 US: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 57

TABLE 52 US: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 57

TABLE 53 US: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 58

TABLE 54 CANADA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 58

TABLE 55 CANADA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 58

TABLE 56 CANADA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 59

TABLE 57 LATIN AMERICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 59

TABLE 58 LATIN AMERICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 59

TABLE 59 LATIN AMERICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 60

TABLE 60 ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 61

TABLE 61 ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 62

TABLE 62 ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 62

TABLE 63 ASIA-PACIFIC: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 62

TABLE 64 JAPAN: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 62

TABLE 65 JAPAN: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 63

TABLE 66 JAPAN: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 63

TABLE 67 CHINA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 63

TABLE 68 CHINA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 63

TABLE 69 CHINA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 64

TABLE 70 INDIA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 64

TABLE 71 INDIA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 64

TABLE 72 INDIA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 65

TABLE 73 SOUTH KOREA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 65

TABLE 74 SOUTH KOREA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 65

TABLE 75 SOUTH KOREA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 66

TABLE 76 AUSTRALIA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 66

TABLE 77 AUSTRALIA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 66

TABLE 78 AUSTRALIA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 67

TABLE 79 REST OF ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 67

TABLE 80 REST OF ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 67

TABLE 81 REST OF ASIA-PACIFIC: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 82 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 69

TABLE 83 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 69

TABLE 84 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 70

TABLE 85 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 70

TABLE 86 MIDDLE EAST: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 70

TABLE 87 MIDDLE EAST: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 70

TABLE 88 MIDDLE EAST: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 71

TABLE 89 AFRICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 71

TABLE 90 AFRICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 71

TABLE 91 AFRICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 72

TABLE 92 MAJOR PLAYERS IN THE GLOBAL FERTILITY SERVICES MARKET 73

TABLE 93 COMPETITOR DASHBOARD: GLOBAL FERTILITY SERVICES MARKET 75

TABLE 94 ACQUISITION 76

TABLE 95 COLLABORATION 76

TABLE 96 EXPANSION 76

TABLE 97 DEVELOPMENT 77

TABLE 98 JOINT VENTURE 77

TABLE 99 PRODUCT LAUNCH/PRODUCT APPROVAL 77

TABLE 100 MERCK KGAA: PRODUCTS/SERVICES OFFERED 79

TABLE 101 MERCK KGAA: KEY DEVELOPMENTS 80

TABLE 102 COOPERSURGICAL, INC.: PRODUCTS/SERVICES OFFERED 83

TABLE 103 COOPERSURGICAL, INC.: KEY DEVELOPMENTS 84

TABLE 104 CARE FERTILITY: PRODUCTS/SERVICES OFFERED 86

TABLE 105 FERRING BV: PRODUCTS/SERVICES OFFERED 88

TABLE 106 FERRING BV: KEY DEVELOPMENTS 89

TABLE 107 INVO BIOSCIENCE: PRODUCTS/SERVICES OFFERED 90

TABLE 108 INVO BIOSCIENCE: KEY DEVELOPMENTS 91

TABLE 109 VITROLIFE: PRODUCTS/SERVICES OFFERED 93

TABLE 110 VITROLIFE: KEY DEVELOPMENTS 94

TABLE 111 MONASH IVF GROUP: PRODUCTS/SERVICES OFFERED 97

TABLE 112 MONASH IVF GROUP: KEY DEVELOPMENTS 97

TABLE 113 COOK: PRODUCTS/SERVICES OFFERED 99

TABLE 114 COOK: KEY DEVELOPMENTS 100

TABLE 115 FUJIFILM IRVINE SCIENTIFIC: PRODUCTS/SERVICES OFFERED 103

TABLE 116 FUJIFILM IRVINE SCIENTIFIC: KEY DEVELOPMENTS 103

TABLE 117 KITAZATO CORPORATION: PRODUCTS/SERVICES OFFERED 105

TABLE 118 KITAZATO CORPORATION: KEY DEVELOPMENTS 106

13 LIST OF FIGURES

FIGURE 1 GLOBAL FERTILITY SERVICES MARKET STRUCTURE 15

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 21

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL FERTILITY SERVICES MARKET 24

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL FERTILITY SERVICES MARKET 29

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL FERTILITY SERVICES MARKET 31

FIGURE 6 GLOBAL FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020 & 2027 (USD MILLION) 34

FIGURE 7 GLOBAL FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020 & 2027 (USD MILLION) 37

FIGURE 8 GLOBAL FERTILITY SERVICES MARKET FOR ART, BY TREATMENT TYPE, 2020 & 2027 (USD MILLION) 38

FIGURE 9 GLOBAL FERTILITY SERVICES MARKET, BY REGION, 2020 & 2027 (USD MILLION) 42

FIGURE 10 EUROPE: FERTILITY SERVICES MARKET SHARE, BY REGION 2020 (%) 43

FIGURE 11 WESTERN EUROPE: FERTILITY SERVICES MARKET SHARE, BY COUNTRY, 2020 (%) 45

FIGURE 12 AMERICAS: FERTILITY SERVICES MARKET SHARE, BY REGION, 2020 (%) 54

FIGURE 13 NORTH AMERICA: FERTILITY SERVICES MARKET SHARE, BY COUNTRY, 2020 (%) 56

FIGURE 14 ASIA-PACIFIC: FERTILITY SERVICES MARKET SHARE, BY COUNTRY, 2020 (%) 61

FIGURE 15 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET SHARE, BY REGION, 2020 (%) 69

FIGURE 16 BENCHMARKING OF MAJOR COMPETITORS 74

FIGURE 17 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 79

FIGURE 18 MERCK KGAA: SWOT ANALYSIS 80

FIGURE 19 COOPERSURGICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT 83

FIGURE 20 COOPERSURGICAL, INC.: SWOT ANALYSIS 85

FIGURE 21 CARE FERTILITY: SWOT ANALYSIS 87

FIGURE 22 FERRING BV: SWOT ANALYSIS 89

FIGURE 23 INVO BIOSCIENCE: FINANCIAL OVERVIEW SNAPSHOT 90

FIGURE 24 INVO BIOSCIENCE: SWOT ANALYSIS 91

FIGURE 25 VITROLIFE: FINANCIAL OVERVIEW SNAPSHOT 92

FIGURE 26 VITROLIFE: SWOT ANALYSIS 95

FIGURE 27 MONASH IVF GROUP: FINANCIAL OVERVIEW SNAPSHOT 96

FIGURE 28 MONASH IVF GROUP: SWOT ANALYSIS 98

FIGURE 29 COOK: SWOT ANALYSIS 101

FIGURE 30 FUJIFILM IRVINE SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT 102

FIGURE 31 FUJIFILM IRVINE SCIENTIFIC: SWOT ANALYSIS 104

FIGURE 32 KITAZATO CORPORATION: SWOT ANALYSIS 106

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.